Cargando…
The optimal threshold of high post-treatment platelet reactivity could be defined by a point-of-care VerifyNow P2Y12 assay
Autores principales: | Jeong, Young-Hoon, Kim, In-Suk, Choi, Bong-Ryong, Kwak, Choong Hwan, Hwang, Jin-Yong |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2519246/ https://www.ncbi.nlm.nih.gov/pubmed/18617479 http://dx.doi.org/10.1093/eurheartj/ehn313 |
Ejemplares similares
-
Different Influences of Hematocrit on the Results of Two Point-Of-Care Platelet Function Tests, the VerifyNow Assay and Multiple Electrode Platelet Aggregometry
por: Kim, Yun Gi, et al.
Publicado: (2014) -
Impact of Routine Platelet Reactivity Testing with VerifyNow Assay on Antiplatelet Choice After Percutaneous Coronary Intervention
por: Mshelbwala, Fakilahyel S, et al.
Publicado: (2020) -
Periprocedural Variability of Platelet Functions in Carotid Artery Stenting: An Analysis Using VerifyNow
por: Yoshimura, Masataka, et al.
Publicado: (2021) -
Performance comparison of aspirin assay between Anysis and VerifyNow: Assessment of therapeutic platelet inhibition in patients with cardiac diseases
por: Piao, Jinxiang, et al.
Publicado: (2021) -
Use of the VerifyNow point of care assay to assess the pharmacodynamic effects of loading and maintenance dose regimens of prasugrel and ticagrelor
por: Angiolillo, Dominick J., et al.
Publicado: (2021)